Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia

NCT07037836 is registered in ClinicalTrials.gov with Bastiaan Driehuys as lead sponsor.

NCT NCT07037836
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07037836 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
Lead sponsor
Bastiaan Driehuys
Phase
Phase 2
Overall status
Recruiting
Start date
September 29, 2025
Completion date
July 1, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd (chronic obstructive pulmonary disease), hypoxemia